Georgia Life Sciences Partners with U.S. Chamber Foundation to Bring Real-World Innovation to Georgia Classrooms

Georgia Life Sciences Partners with U.S. Chamber Foundation to Bring Real-World Innovation to Georgia Classrooms

60 + high school students tackle real industry challenges through national EPIC program


July 7, 2025

ATLANTA – Georgia Life Sciences (GLS) has successfully completed its first collaboration with the U.S. Chamber of Commerce Foundation’s Employer Provided Innovation Challenges (EPIC) program, bringing hands-on, real-world learning into Georgia classrooms and spotlighting the state’s growing leadership in workforce innovation.

 

Through this groundbreaking initiative, GLS developed and piloted three challenge-based projects designed to spark student interest in the life sciences:

  • Navigating Medical Device Regulatory Pathways
  • Innovative Solutions in Food Production
  • Automated Biomanufacturing

 

Over 60 high school students across the state formed 12 teams to tackle these challenges, working directly with industry volunteer mentors to co-design creative solutions. All participants earned credentials for their work, demonstrating not only career awareness but real-world readiness for Georgia’s growing bioscience sector.

 

One standout team—composed of homeschool students from the Georgia Black Home Educators Network (GBHEN), sponsored by Blue Heron Urban Farm and Sanctuary—was selected to present at the EPIC National Convening on June 24 in Washington, D.C., hosted at the U.S. Chamber of Commerce. The team shared their innovations in sustainable food production, highlighting the role of student ingenuity in solving global challenges.

 

“This program gave students a window into the real world of biotech, medical devices, and agtech,” said Dr. Phil Gibson, Executive Director for the Georgia Life Sciences Institute. “It also gave our industry partners a powerful new way to engage with the future workforce—and even shape it.”

 

EPIC, launched by the U.S. Chamber Foundation, is redefining the connection between business innovation and workforce development by giving students access to real problems, real collaboration, and real career exposure.

 

This effort is part of Georgia Life Sciences’ broader mission to build a sustainable talent pipeline in the life sciences—from classroom to career. Through initiatives like this partnership with the Us Chamber Foundation and the public/private partnership with Georgia’s Department of Education, the Biotech Teacher Training Initiative (BTTI), GLS provides immersive, standards-aligned professional development for Georgia educators to bring modern biotech concepts and techniques into biology, chemistry, agriculture, and environmental science classrooms statewide.

 

Why It Matters

As Georgia’s life sciences industry continues to grow, workforce demand is outpacing supply. Programs like EPIC play a vital role in bridging that gap by increasing industry awareness early in the pipeline. Building student familiarity with bioscience careers—and connecting them with real industry mentors—is essential to strengthening Georgia’s long-term competitiveness in biotechnology, biomanufacturing, and global health innovation.

 

About Georgia Life Sciences

Georgia Life Sciences is the statewide association advancing the life sciences ecosystem through policy advocacy, economic development, workforce initiatives, and industry-led innovation. From breakthrough biomanufacturing to patient access, GLS is committed to making Georgia a leader in global health and biotechnology.

December 10, 2025
Georgia Life Sciences has joined 43 state and regional life sciences organizations in signing a national Council of State Bioscience Associations (CSBA) letter calling on Congress to take immediate action on three bipartisan policy priorities that are essential to sustaining U.S. leadership in biomedical innovation and supporting patients nationwide. With Congress back in session and several critical programs at risk of expiring, the letter urges congressional leaders to advance the following provisions without delay: 1. Reauthorize the Rare Pediatric Disease Priority Review Voucher (PPRV) Program The PPRV program has been instrumental in incentivizing the development of therapies for children with rare and life-threatening conditions. Its lapse threatens to slow or halt research that families across the country are counting on. 2. Extend the SBIR/STTR Programs The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs provide crucial early-stage capital for emerging biotech and medtech companies—many of them in Georgia. Without reauthorization, hundreds of innovative small businesses face uncertainty, jeopardizing new therapies, diagnostics, and technologies in the pipeline, 3. Advance PBM Transparency Reforms Greater transparency and accountability within pharmacy benefit manager (PBM) practices are needed to ensure that savings reach patients and employers. Reforming PBM operations is essential to strengthening access and affordability across the healthcare system. A Unified Message from the Life Sciences Community The sign-on letter reflects broad, bipartisan alignment across the national life sciences ecosystem: researchers, entrepreneurs, investors, patient advocates, and state associations all share a common message— these programs underpin America’s global competitiveness and are vital to patients who rely on continued scientific progress. Georgia Life Sciences has shared the letter with members of Georgia’s congressional delegation and will continue engaging with policymakers to emphasize the importance of swift action.
December 7, 2025
Georgia Life Sciences is proud to stand with patient advocates, providers, and employers across the state in urging Congress to take meaningful action on pharmacy benefit manager (PBM) reform. We recently signed on to a joint letter to Georgia’s Congressional Delegation stressing the urgent need for transparency, fair practices, and policies that ensure savings flow directly to patients.
December 4, 2025
Georgia Life Sciences’ CEO, Maria Thacker Goethe shares her perspective on the value of Georgia’s research universities in this month’s issue of Georgia Trend. “Georgia research institutions have felt a very significant impact from the federal rollbacks, specifically in NIH and NSF funding. Thacker Goethe’s message about the impact of research cuts is simple: Disruption shatters the foundational trust researchers have in grant continuity….” To read the full article, click here .
MORE POSTS